CRMP-5 neuronal autoantibody: Marker of lung cancer and thymoma-related autoimmunity

Annals of Neurology

Volumn 49, Issue 2, 2001, Pages 146-154

  Yu, Zhiya ^a   Kryzer, Thomas J ^a,b   Griesmann, Guy E ^a,b   Kim, Kwang Kuk ^b   Benarroch, Eduardo E ^b   Lennon, Vanda A ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANNA 1 AUTOANTIBODY; AUTOANTIBODY; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; IMMUNOGLOBULIN G ANTIBODY; PCA 1 AUTOANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTONOMIC NEUROPATHY; CEREBELLAR ATAXIA; CHOREA; CRANIAL NEUROPATHY; DEMENTIA; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEUROMUSCULAR JUNCTION DISORDER; NUCLEOTIDE SEQUENCE; OPTIC NERVE DISEASE; PARANEOPLASTIC NEUROPATHY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SMELLING DISORDER; SMOKING; THYMOMA;

AMINO ACID SEQUENCE; AUTOIMMUNITY; BASE SEQUENCE; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; THYMOMA; THYMUS NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035138566     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E     Document Type: Article

References (32)

1. Paraneoplastic syndromes
2. Calcium channel and related paraneoplastic disease autoantibodies
3. 7) types coexpressed in a small-cell lung carcinoma
4. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer
5. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome
6. Calcium-channel antibodies in Lambert-Eaton myasthenic syndrome and other paraneoplastic syndromes
7. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes
8. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor
9. New Purkinje cell antibody (PCA-2): Marker of lung cancer-related neurological autoimmunity
10. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume
11. Collapsin induced growth cone collapse mediated by an intracellular protein related to UNC-33
12. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes
13. Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes
14. Special Correspondence: The case for a descriptive generic nomenclature: Clarification of immunostaining criteria for PCA-1, ANNA-1 and ANNA-2 autoantibodies
15. Paraneoplastic anti-purkinje and type-1 anti-neuronal nuclear autoantibodies bind selectively to central, peripheral and autonomic nervous system cells
16. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis
17. Internal sequences from proteins digested in polyactylamide gels
18. Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer
19. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis
20. Identification of the structural similarity in the functionally related amidohydrolases acting on the cyclic amide ring
21. Paraneoplastic and oncological profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies
22. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum associated neuropathy
23. Brain CRMP forms heterotetramers similar to liver dihydropyrimidinase
24. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals
25. Optic neuropathy: A rare paraneoplastic syndrome
26. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: Clinical response to excision of the primary tumor
27. Molecular cloning of a new unc-33-like cDNA from rat brain and its relation to paraneoplastic neurological syndromes
28. Identification of human tumor antigens by serological expression cloning (SEREX)
29. Tumor-specific killer cells in paraneoplastic cerebellar degeneration
30. Induction of MHC class I genes in neurons
31. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis
32. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration